Ting La
Callaghan, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Risk prediction of echinococcosis in China under climate change: a One Health approach.
Journal: Parasites & vectors
Published: February 25, 2026
Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 11, 2026
Recurrent anti-TIF1γ-positive dermatomyositis coexisting with postoperative parotid lymphoepithelial carcinoma: a case report with pathogenesis analysis.
Journal: Frontiers in immunology
Published: November 18, 2025
The lncRNA PARylator promotes PARP1 activation and resistance to DNA‑damaging therapy in esophageal squamous cell carcinoma.
Journal: Experimental hematology & oncology
Published: October 29, 2025
Environmental transmission from bamboo rats: Mapping current and future talaromycosis risk in China under climate change.
Journal: One health (Amsterdam, Netherlands)
Published: August 12, 2025
Associations between triglyceride glucose-body mass index and cardiovascular, renal, hepatic and bone biomarkers in patients with type 2 diabetes: a single-center, cross-sectional study.
Journal: Frontiers in endocrinology
Published: January 25, 2025
Erratum: Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells: Erratum.
Journal: Theranostics
Published: December 25, 2024
Efficacy of toripalimab in combination with anlotinib in recurrent undifferentiated pleomorphic sarcoma of the sinonasal region: a case report with biomarker analysis.
Journal: Frontiers in immunology
Published: December 07, 2024
Ticks jump in a warmer world: Global distribution shifts of main pathogenic ticks are associated with future climate change.
Journal: Journal of environmental management
Published: September 03, 2024
DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation.
Journal: Journal of Cancer
Published: August 12, 2024
Last Updated: 09/26/2026